Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.39
-0.01 (-0.19%)
May 27, 2026, 4:00 PM EDT - Market closed
Bausch Health Companies Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Bausch Health Companies stock has a consensus rating of "Hold" and an average price target of $7.50. The average 1-year stock price forecast is 39.15% higher than the current stock price, while the lowest is $6.00 (+11.32%) and the highest is $9.00 (+66.98%).
Price Target: $7.50 (+39.15%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 8 | 8 | 8 | 8 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 1, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $7 | Hold | Maintains | $7 | +29.87% | Apr 30, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 30, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $9 | Hold | Maintains | $9 | +66.98% | Apr 30, 2026 |
| Barclays | Barclays | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +29.87% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
10.84B
from 10.27B
Increased by 5.60%
Revenue Next Year
10.86B
from 10.84B
Increased by 0.18%
EPS This Year
4.48
from 0.42
Increased by 966.51%
EPS Next Year
4.38
from 4.48
Decreased by -2.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 11.4B | 11.4B | |||||
| Avg | 10.8B | 10.9B | |||||
| Low | 10.5B | 10.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 10.6% | 5.6% | |||||
| Avg | 5.6% | 0.2% | |||||
| Low | 2.0% | -3.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 5.00 | 5.24 | |||||
| Avg | 4.48 | 4.38 | |||||
| Low | 4.09 | 3.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 1,090.0% | 17.0% | |||||
| Avg | 966.5% | -2.1% | |||||
| Low | 873.0% | -16.0% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.